Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Fresnillo posts jump in operating profits, announces special dividend

(Sharecast News) - Fresnillo posted a jump in in full-year sales and a surge in operating profits, paving the way for the precious metals miner to unveil a special dividend. "Operationally, we delivered silver production in line with guidance and gold production slightly ahead, with lead and zinc production also up strongly over the year," chief executive officer Octavio Alvídrez said.

"Meanwhile, we have made significant strides in improving efficiencies, optimising mine plans, and advancing key projects, including the full commissioning of the San Carlos shaft at our Fresnillo mine."

Revenues for the year ending in December rose by 26.9% to $3.64bn, helped by higher prices and volumes.

Yet adjusted production costs declined by 2.6% to $1.58bn, thanks to efficiencies and economies of scale, together with the devaluation of the Mexican peso against the Greenback.

Hence, earnings before interest, taxes, depreciation and amortisation more than doubled to reach $1.55bn.

Thanks to that "strong" performance, the miner announced a one-off special dividend of $308m, or 41.8 US cents per share, together with a final dividend of $192.3m or 26.1 US cents.

That took the full-year regular dividend payout to 32.5 US cents.

Net cash at period end stood at $458.3m, while cash and other liquid funds came in at roughly $1.3bn.

-- More to follow --

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.